Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
CABA
#3174
Cabaletta Bio, Inc. Common Stock
3.4
0
USD
+4.29%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+4.29%
Changement Mensuel
+9.32%
Evolution sur 6 mois
+16.04%
Changement Annuel
+200.88%
Clôture Précédente
3.2
6
Open
3.4
0
Bid
Ask
Low
3.4
0
High
3.4
0
Volume
31
Marchés
Actions des Marchés US
Soins de Santé
CABA
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
50.74 M
50.74 M
91.47 M
96.27 M
111.32 M
—
Valuation ratios
Enterprise value
-48.78 M
-61.55 M
-6.58 M
165.05 M
160.81 M
257.73 M
Price to earnings ratio
-0.97
-0.55
-0.56
-0.97
-1.04
-3.12
Price to sales ratio
-2 987.41
—
—
-126.75
-486.76
—
Price to cash flow ratio
-1.27
-0.72
-0.72
-0.97
-0.83
-3.24
Price to book ratio
0.74
0.11
0.12
0.2
0.97
1.39
Enterprise value to EBITDA ratio
0.4
—
—
-0.94
-0.93
—
Profitability ratios
Return on assets %
-0.18
-0.22
-0.2
-0.24
-0.25
-0.91
Return on equity %
-0.21
-0.3
-0.25
-0.32
-0.37
-1.24
Return on invested capital %
—
-341.72
-334.89
-336.24
-294.08
-1 306.94
Gross margin %
100
100
100
15.39 K
100
15.69 K
Operating margin %
88.91 K
128.06 K
143.46 K
54.81 K
53.94 K
380.26 K
EBITDA margin %
88.03 K
126.48 K
142.2 K
70.54 K
54.72 K
393.95 K
Net margin %
85.75 K
123.94 K
141.02 K
52.78 K
53.06 K
370.81 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.15
3.96
4.78
3.6
2.77
15.1
Inventory turnover
—
—
—
—
—
—
Asset turnover
-0
-0
-0
-0
-0
-0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.47
-0.62
-0.62
-0.7
-0.71
-2.65
EBIT per share
-0.68
-0.75
-0.93
-1.21
-0.86
-3.75
EBITDA per share
-0.68
-0.74
-0.92
-1.21
-0.87
-3.75
Total debt per share
—
—
—
—
—
—
Cash per share
3.31
2.67
3.94
3.24
2.7
12.55
Net current asset value per share
3.37
2.73
4.02
3.33
2.8
12.88
Tangible book value per share
3.05
2.4
16.53
23.24
2.24
44.41
Working capital per share
2.82
2.04
3.18
2.41
1.79
9.41
Book value per share
3.08
2.47
3.61
2.82
2.26
11.17
Nouvelles
H.C. Wainwright réitère sa recommandation d’achat sur Cabaletta Bio
Jefferies réitère sa recommandation sur Cabaletta Bio
Jefferies réitère sa recommandation d’achat sur Cabaletta Bio, objectif de 14$
William Blair réitère sa note de surperformance sur l’action Cabaletta Bio
Guggenheim relève l’objectif de cours de Cabaletta Bio suite aux progrès des essais
Cabaletta Bio (CABA) Upgraded to Buy: Here's What You Should Know
Are Medical Stocks Lagging Biodesix (BDSX) This Year?
Kyverna Stock: The King Of The CAR-T Autoimmune Revolution (NASDAQ:KYTX)
Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year?
What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now?
Cabaletta Bio: Do You Buy With The Insiders? (NASDAQ:CABA)
Is Cabaletta Bio (CABA) Outperforming Other Medical Stocks This Year?